![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, January 01, 2010 8:43:47 PM
On December 31, 2009, DARA Pharmaceuticals, Inc., a subsidiary of DARA BioSciences, Inc. (collectively "DARA"), entered into a Stock Purchase Agreement with SurgiVision, Inc. ("SurgiVision") pursuant to which DARA sold 536,712 shares of SurgiVision common stock to SurgiVision. The purchase price for the shares was paid through cancellation of outstanding principal and interest accrued on the January 2009 secured promissory note issued by DARA to SurgiVision in the original principal amount of $500,000. Following the completion of the transaction, DARA will continue to own 1,663,288 shares of SurgiVision common stock and warrants to purchase an additional 405,000 shares.
--------------------------------------------------------------------------------
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM